Chugai Pharmaceutical Co. Ltd.

CHGCY | OTC

Price Alert Chart Builder DCF Calculator

$22.30

+$0.18 (+0.81%)

At close: Nov 5, 2026, 3:59 PM ET

$22.25

-$0.05 (-0.22%)

After-hours: Nov 5, 2026, 4:01 PM ET

Overview Rating Statistics Financials Earnings Ownership Dividends Profile

+0.81%

(1D)

No price chart data available for 1D timeframe.

Rating

Updated: Nov 5, 2026

71.5

Fundamentals Excellent

Market Sentiment Neutral

Moat Wide

Sector Rank #48/1024 (Top 5%)

Full Analysis

Why Price Moved

9 days ago

+1.51%

Shares are trading higher following the company's ...

Key Statistics

Market Data

Market Cap $73.39B

1D Range

22.23 22.58

52W Range

19.08 33.61

Valuation (TTM)

PE 11.37

PB 5.49

EV/EBITDA 15.03

Valuation (NTM)

Forward PE 18.48

Forward PEG 1.29

Price Target $0.00

Cash Flow

FCF Yield 3.1%

SBC Adj. FCF Yield 3.1%

SBC Impact N/A

Margins

Gross Margin 71.5%

Operating Margin 46.5%

FCF Margin 25.7%

Growth (CAGR)

Revenue 3Y | 5Y 3.5% | 9.8%

Dil EPS 3Y | 5Y 14.4% | 14.4%

FCF 3Y | 5Y 24.0% | 15.0%

Returns

ROA 21.2%

ROE 25.0%

ROIC 22.2%

Financial Health

Net Cash

¥869B ($5.52B)

Current Ratio 6.39

Interest Coverage 720.02

Dividends

Div Yield 5.65%

Payout Ratio 0.4%

FCF Payout Ratio 96.5%

All Key Statistics

Loading financial charts...

Profile

Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Over...

Sector Healthcare

Industry Drug Manufacturers - General

Employees 7,872

IPO Date Aug 3, 2012

Website www.chugai-pharm.co.jp

Fiscal Year January - December

Full Company Profile

Latest News

9 days ago · seekingalpha.com

Chugai Pharmaceutical Co., Ltd. (CHGCY) Q3 2026 Earnings Call Transcript

3 months ago · seekingalpha.com

Chugai Pharmaceutical Co., Ltd. (CHGCY) Q2 2026 Earnings Call Transcript